1. Home
  2. JFIN vs GOSS Comparison

JFIN vs GOSS Comparison

Compare JFIN & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JFIN
  • GOSS
  • Stock Information
  • Founded
  • JFIN 2011
  • GOSS 2015
  • Country
  • JFIN China
  • GOSS United States
  • Employees
  • JFIN N/A
  • GOSS N/A
  • Industry
  • JFIN Finance: Consumer Services
  • GOSS Biotechnology: Pharmaceutical Preparations
  • Sector
  • JFIN Finance
  • GOSS Health Care
  • Exchange
  • JFIN Nasdaq
  • GOSS Nasdaq
  • Market Cap
  • JFIN 682.1M
  • GOSS 586.6M
  • IPO Year
  • JFIN 2019
  • GOSS 2019
  • Fundamental
  • Price
  • JFIN $11.15
  • GOSS $2.52
  • Analyst Decision
  • JFIN
  • GOSS Strong Buy
  • Analyst Count
  • JFIN 0
  • GOSS 6
  • Target Price
  • JFIN N/A
  • GOSS $8.60
  • AVG Volume (30 Days)
  • JFIN 90.9K
  • GOSS 4.5M
  • Earning Date
  • JFIN 11-19-2025
  • GOSS 11-06-2025
  • Dividend Yield
  • JFIN 7.06%
  • GOSS N/A
  • EPS Growth
  • JFIN 33.85
  • GOSS N/A
  • EPS
  • JFIN 4.21
  • GOSS N/A
  • Revenue
  • JFIN $908,895,698.00
  • GOSS $40,237,000.00
  • Revenue This Year
  • JFIN N/A
  • GOSS N/A
  • Revenue Next Year
  • JFIN N/A
  • GOSS $34.10
  • P/E Ratio
  • JFIN $2.68
  • GOSS N/A
  • Revenue Growth
  • JFIN 8.19
  • GOSS N/A
  • 52 Week Low
  • JFIN $5.18
  • GOSS $0.66
  • 52 Week High
  • JFIN $19.23
  • GOSS $3.60
  • Technical
  • Relative Strength Index (RSI)
  • JFIN 44.45
  • GOSS 45.62
  • Support Level
  • JFIN $10.18
  • GOSS $2.32
  • Resistance Level
  • JFIN $11.64
  • GOSS $2.64
  • Average True Range (ATR)
  • JFIN 0.46
  • GOSS 0.19
  • MACD
  • JFIN 0.17
  • GOSS -0.09
  • Stochastic Oscillator
  • JFIN 73.97
  • GOSS 23.48

About JFIN Jiayin Group Inc.

Jiayin Group Inc is China's technology service group. It is an enterprise engaged in technological innovation services. It is committed to using big data, cloud computing, artificial intelligence and other technologies to connect consumers and financial institutions in consumption scenarios so that every user can enjoy efficient and convenient technology services. The company has engraved technological innovation into the company's development genes since its establishment, adheres to the dual drive of digital plus technology, and focuses on building a cloud service platform and intelligent risk control system with big data drive as the core concept.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Share on Social Networks: